Appointment follows commencement of Phase 2 RESOLVE-1 trial of oral NLRP3 inflammasome inhibitor NT-0796 in patients with ...

AstraZeneca has revealed the ... but also the built environment of Cambridge and the environment, resulting in a low rise building with many eco-features, such as "green roofs" across the site.

How are contractors meeting the challenges of designing life sciences buildings that are fit for the future? In south London, ...

The Cambridge Independent Business Awards 2025 are now open for entry. Following the success of our inaugural awards last year, we are delighted to announce that the search is now on for the best in ...

AZ has asked Cambridge City Council’s planning committee to allow builders to stay late to get work done as fast as possible. AstraZeneca said that the with the scaled-up building work ...

Sotheby’s has finally revealed what its plans are for Breuer’s building. Today, the international auction house, alongside the Pritzker prize-winning architecture firm Herzog & de Meuron, unveiled ...

Even years later, patients whose symptoms were initially dismissed experience distrust and uncertainty with clinicians.

Collaboration leverages cutting-edge reformulation expertise to generate cross-species insights, fast-track human clinical programs, and seeks to capture commercial potential in the $15 billion animal ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Trump said Friday that he would double steel and aluminium import tariffs to 50% from next week, the latest salvo in his trade wars aimed at protecting domestic industries. "We're going to bring it ...

The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule ...

AstraZeneca announced a strategic research collaboration with CSPC Pharmaceuticals to advance AI-enabled drug discovery. This partnership aims to develop novel o ...